PRRC2A and neoplasm: Moreover, in APKS mouse tumor organoids harboring mutations in Apc, Tp53, Kras, and Smad4, siRNA‐mediated Prrc2a knockdown significantly suppressed organoid growth, as evidenced by decreased organoid area after 5 days of culture (Figure 1G,H).